HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

loviride

structure given in first source; inhibits virion and recombinant HIV-1 reverse transcriptase

Also Known As:

R 89439; R-89439

Networked: 5 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Related Diseases

1.	Nausea 03/01/1995 - "The first randomized trial involving Loviride with zidovudine has shown a sustained increase in CD4 cells with headache, nausea, and diarrhea as the most common side effects. "
2.	Infections 05/17/1997 - "Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial."
3.	Headache (Headaches) 03/01/1995 - "The first randomized trial involving Loviride with zidovudine has shown a sustained increase in CD4 cells with headache, nausea, and diarrhea as the most common side effects. "
4.	Diarrhea 03/01/1995 - "The first randomized trial involving Loviride with zidovudine has shown a sustained increase in CD4 cells with headache, nausea, and diarrhea as the most common side effects. "
5.	Disease Progression 10/04/1996 - "The rate of disease progression was 17 percent in the placebo group, 9 percent in the group which added 3TC alone, and 8 percent in the group which added 3TC plus loviride. "

Related Drugs and Biologics

1.	Zidovudine (Retrovir)
2.	Lamivudine (Epivir)
3.	Nevirapine (Viramune)
4.	emivirine